Session II: Genomics 2018 – What Have We Learned

Genomics 2018 – What Have We Learned?

During session II of Myeloma2018, Yuan Xiao Zhu, PhD, presents on FAM46C, one of the most frequently mutated genes in multiple myeloma, and how it influences disease progression and treatment outcomes.